When is BRCA genetic testing recommended for ovarian cancer?

Testing usually examines BRCA1 and BRCA2 in a blood or saliva sample. A positive result may help the oncology team consider treatments that target weaknesses in cancer cells and may prompt discussion of cancer risks in other organs. A negative result lowers the chance of a BRCA change but may not explain every inherited risk. Some results are uncertain and need careful interpretation.

Ask the oncology team or a genetic counsellor how testing fits with your diagnosis, treatment timing, and family history. Before giving a sample, discuss what the result could mean for relatives and whether the laboratory also checks other inherited genes. Keep a copy of the report so future clinicians can use the exact finding when planning care.

Contact your oncology team promptly if you have an ovarian cancer diagnosis and genetic testing has not been discussed, especially before treatment decisions are finalised. Seek urgent medical help for severe breathing difficulty, sudden weakness, heavy bleeding, or rapidly worsening pain; these symptoms need assessment regardless of genetic results.

Which BRCA test is appropriate for me? Will it look for inherited changes, tumour changes, or both? Could the result alter my treatment plan? Should my relatives consider counselling or testing? How will an uncertain result be explained and followed?